FIGS Inc (NYSE:FIGS) shares are climbing on Friday after the healthcare‑apparel company delivered a standout fourth‑quarter report that blew past Wall Street expectations, with earnings coming in far stronger than analysts anticipated.FIGS stock is approaching key resistance levels. Why are FIGS shares at highs?The rally gained additional momentum after KeyBanc upgraded the stock from Sector Weight to Overweight.Earnings Strength Fuels The MoveFIGS posted earnings of 10 cents per share, far above the 2 cent ...

Group 1 - The bank expects to complete the Mediobanca integration within this year [1] - The bank has guided for revenue growth of 4.6% annually [1] - Revenue is projected to reach €9.5 billion by 2030 [1]

Several established products saw sizable declines. Peters said glucagon sales fell 45% to $14.1 million , citing increased competition and a market shift toward ready-to-use products such as BAQSIMI. Epinephrine sales declined 9% to $17.1 million due to increased competition for the company’s epinephrine multi-dose vial products, partially offset by higher unit volumes for epinephrine pre-filled syringes amid supplier shortages during the quarter.Newer products also began contributing, including $4.4 millio ...

Alpha Teknova (NasdaqGM:TKNO) Q4 2025 Earnings call February 26, 2026 05:30 PM ET Speaker2Good day, and welcome to Teknova's fourth quarter and full year 2025 financial results call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star one one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, pres ...

Tutor Perini (NYSE:TPC) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsAdam Thalhimer - Director of ResearchAlex Rygiel - Managing DirectorGary Smalley - CEO and PresidentJorge Casado - SVP of Investor RelationsLiam Burke - Managing DirectorRyan Soroka - EVP and CFOSteven Fisher - Managing DirectorConference Call ParticipantsMichael Dudas - Partner and Equity Research AnalystOperatorGood day, ladies and gentlemen, and welcome to the Tutor Perini Corporation's fourth quarter 2025 ear ...

Castle Biosciences (NasdaqGM:CSTL) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsCamilla Zuckero - Vice President, Investor Relations and Corporate AffairsCarlos Peniche - Former Equity Research AssociateDerek Maetzold - Founder, President, and CEOFrank Stokes - CFOThomas Heinzen - Managing Director in Healthcare Investment BankingConference Call ParticipantsAlex Vukasin - Healthcare Equity Research AnalystJosh R. Waldman - Equity Research AnalystMason Carrico - Research AnalystMat ...

Management is pivoting to a high-growth strategy by expanding sales capacity in priority geographies that exhibit favorable market access and established distributor relationships.Oncology performance remained a stable revenue base, with CINVANTI showing resilience against competitive pressures while the company continues the planned wind-down of SUSTOL.The implementation of permanent J-Codes for ZYNRELEF and APONVIE has improved reimbursement clarity, facilitating broader adoption across hospitals and ambu ...

For the quarter ended December 2025, Integra LifeSciences (IART) reported revenue of $434.93 million, down 1.7% over the same period last year. EPS came in at $0.83, compared to $0.97 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $434.35 million, representing a surprise of +0.13%. The company delivered an EPS surprise of +4.73%, with the consensus EPS estimate being $0.79.While investors closely watch year-over-year changes in headline numbers -- revenue and earnin ...

MannKind (NasdaqGM:MNKD) Q4 2025 Earnings call February 26, 2026 09:00 AM ET Company ParticipantsBrandon Folkes - Managing DirectorChris Prentiss - CFOMichael Castagna - CEORoanna Ruiz - Senior Managing DirectorConference Call ParticipantsNone - AnalystNone - AnalystOperatorGood morning, and welcome to the MannKind Corporation Q4 and full year 2025 financial results earnings call. As a reminder, this call is being recorded on February 26, 2026, and will be available for replay on the MannKind Corporation we ...

Universal Health Services (NYSE:UHS) Q4 2025 Earnings call February 26, 2026 09:00 AM ET Speaker9Good day. Thank you for standing by. Welcome to the Q4 2025 Universal Health Services Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question-and-answer session. To ask a question during the session, you'll need to press star one on your telephone. You will hear an automated message advising your hand is raised. To withdraw your ...